Proceedings from an international consensus meeting on ablation in urogenital diseases
Percutaneous image-guided ablation techniques are a consolidated therapeutic alternative for patients with high preoperative surgical risk for the management of oncological diseases in multiple body districts. Each technique has both pros and cons according to the type of energy delivered, mechanism of action, and site of application. The present article reviews the most recent literature results on ablation techniques applied in the field of genitourinary diseases (kidney, adrenal glands, prostate, and uterus), describing the advantages of the use of each technique and their technical limitations and summarizing the major recommendations from an international consensus meeting. CRITICAL RELEVANT STATEMENT: The article critically evaluates the efficacy and safety of ablation therapies for various genitourinary tract diseases, demonstrating their potential to improve patient outcomes and advance clinical radiology by offering minimally invasive, effective alternatives to traditional surgical treatments. KEY POINTS: Ablation therapies are effective alternatives to surgery for renal cell carcinoma. Ablation techniques offer effective treatment for intermediate-risk prostate cancer. Ablation is a promising tool for adrenal tumor management. Ablation reduces fibroid symptoms and volume, offering an alternative to surgery.
Authors
- Alessandra De Filippis
- Muneeb Ahmed (ORCID: https://orcid.org/0000-0003-0323-8260)
- Dimitri Filippiadis
- David C. Madoff (ORCID: https://orcid.org/0000-0003-3461-437X)
- Shraga Nahum Goldberg (ORCID: https://orcid.org/0000-0003-2940-9822)
- Anna Rita Scrofani (ORCID: https://orcid.org/0000-0002-2500-5110)
- Evis Sala (ORCID: https://orcid.org/0000-0002-5518-9360)
- Roberto Iezzi (ORCID: https://orcid.org/0000-0002-2791-481X)
- Andrea Contegiacomo (ORCID: https://orcid.org/0000-0003-1489-6314)
- Alexis Kelekis (ORCID: https://orcid.org/0000-0002-5429-6041)
- Thomas D. Atwell (ORCID: https://orcid.org/0000-0001-7338-7320)
- Alessandro Maresca (ORCID: https://orcid.org/0000-0003-4407-5672)
- Alessandro Posa (ORCID: https://orcid.org/0000-0001-9617-3413)
- Andrew J. Gunn (ORCID: https://orcid.org/0000-0001-9081-446X)
- Jing Zhang (ORCID: https://orcid.org/0000-0002-4784-2278)
- Timothy McClure
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- National and Kapodistrian University of Athens (GR)
- Cornell University (US)
- Hadassah Medical Center (IL)
- Agostino Gemelli University Polyclinic (IT)
- Chinese PLA General Hospital (CN)
- University of Alabama at Birmingham (US)
- Yale University (US)
- University Hospital Foundation (CA)
- Mayo Clinic in Arizona (US)
Publication Details
- Journal
- Insights into Imaging
- Published
- 2024-11-08
- DOI
- https://doi.org/10.1186/s13244-024-01841-2
- Citations
- 1
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.42